Literature DB >> 9435549

Reduction of shock-induced gastric damage by a nitric oxide-releasing aspirin derivative: role of neutrophils.

J L Wallace1, W McKnight, T L Wilson, P Del Soldato, G Cirino.   

Abstract

The gastric damage associated with hemorrhagic shock appears to occur, at least in part, through neutrophil-dependent mechanisms. Nitric oxide (NO)-releasing derivatives of aspirin have been shown to spare the gastrointestinal tract of injury. As NO can inhibit neutrophil adherence, it is possible that such a derivative of aspirin (NCX-4016) would exert inhibitory effects on neutrophil adherence and therefore be capable of protecting the stomach against shock-induced gastric damage. This hypothesis was tested in this study. Oral administration of NCX-4016 or glyceryl trinitrate or depletion of circulating neutrophils with antineutrophil serum significantly reduced the extent of gastric damage induced by hemorrhagic shock, whereas aspirin had no effect. NCX-4016 and antineutrophil serum pretreatment resulted in significant preservation of gastric blood flow during the shock period. Moreover, NCX-4016, but not aspirin, was capable of inhibiting N-formyl-Met-Leu-Phe-induced leukocyte adherence to postcapillary mesenteric venules. These results suggest that an NO-releasing aspirin derivative reduces the susceptibility of the stomach to shock-induced damage through inhibitory effects on neutrophil adherence to the vascular endothelium.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9435549     DOI: 10.1152/ajpgi.1997.273.6.G1246

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Hydrogen sulfide: a rescue molecule for mucosal defence and repair.

Authors:  John L Wallace
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

Review 2.  Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyond.

Authors:  Jan C Becker; Wolfram Domschke; Thorsten Pohle
Journal:  Br J Clin Pharmacol       Date:  2004-12       Impact factor: 4.335

Review 3.  Risk factors for gastrointestinal complications in aspirin users: review of clinical and experimental data.

Authors:  Felix W Leung
Journal:  Dig Dis Sci       Date:  2008-02-28       Impact factor: 3.199

Review 4.  Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.

Authors:  R La Corte; M Caselli; G Castellino; G Bajocchi; F Trotta
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

5.  Vasorelaxant effects of a nitric oxide-releasing aspirin derivative in normotensive and hypertensive rats.

Authors:  M N Muscará; F Lovren; W McKnight; M Dicay; P del Soldato ; C R Triggle; J L Wallace
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

6.  Lack of gastric toxicity of nitric oxide-releasing indomethacin, NCX-530, in experimental animals.

Authors:  K Takeuchi; H Mizoguchi; H Araki; Y Komoike; K Suzuki
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

7.  Low gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in rats with cirrhosis and arthritis.

Authors:  S Kato; K Suzuki; H Ukawa; Y Komoike; K Takeuchi
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

Review 8.  Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs.

Authors:  J E Keeble; P K Moore
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

9.  Involvement of alpha(2)-adrenoceptors in the gastric protective effect of nitroglycerin against acidified ethanol-induced mucosal injury.

Authors:  Felix W Leung; Chi Chung Chan
Journal:  Dig Dis Sci       Date:  2007-03-30       Impact factor: 3.199

10.  Intragastric nitroglycerin at a vasodilatory dose attenuates acidified aspirin-induced gastric mucosal injury.

Authors:  Felix W Leung; Chi Chung Chan
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.